Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Nakamura

Showing results (11-20 of 1,044) with videos related to

Pageof 105
Sort By:
Cancer Science|January 15, 2004
Isolation of p53-target genes and their functional analysisYusuke Nakamura
Nature|June 10, 2011
A healthier Japan. Interview by David CyranoskiYusuke Nakamura
Clinical Advances in Hematology & Oncology : H&O|November 6, 2007
The BioBank Japan ProjectYusuke Nakamura
The New England Journal of Medicine|July 25, 2008
Pharmacogenomics and drug toxicityYusuke Nakamura
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|August 10, 2010
[Therapeutic cancer vaccines against gastro-intestinal cancer]Koji Yoshida, Yusuke Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 19, 2006
[BioBank Japan project]Yozo Ohnishi, Yusuke Nakamura
Cell Cycle (Georgetown, Tex.)|May 16, 2013
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cellsSuyoun Chung, Yusuke Nakamura
Trends in Pharmacological Sciences|November 16, 2016
Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized ImmunotherapyXiaolan Deng, Yusuke Nakamura
Seminars in Hematology|June 5, 2003
Prediction of response to imatinib by cDNA microarray analysisRyuzo Ohno, Yusuke Nakamura
Neuropsychiatric Disease and Treatment|May 30, 2017
Productivity and deadweight losses due to relapses of schizophrenia in JapanYusuke Nakamura, Jörg Mahlich
Pageof 105

Showing results (11-20 of 1,044) with videos related to

Sort By:
Pageof 105
Cancer Science|January 15, 2004
Isolation of p53-target genes and their functional analysisYusuke Nakamura
Nature|June 10, 2011
A healthier Japan. Interview by David CyranoskiYusuke Nakamura
Clinical Advances in Hematology & Oncology : H&O|November 6, 2007
The BioBank Japan ProjectYusuke Nakamura
The New England Journal of Medicine|July 25, 2008
Pharmacogenomics and drug toxicityYusuke Nakamura
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|August 10, 2010
[Therapeutic cancer vaccines against gastro-intestinal cancer]Koji Yoshida, Yusuke Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 19, 2006
[BioBank Japan project]Yozo Ohnishi, Yusuke Nakamura
Cell Cycle (Georgetown, Tex.)|May 16, 2013
MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cellsSuyoun Chung, Yusuke Nakamura
Trends in Pharmacological Sciences|November 16, 2016
Cancer Precision Medicine: From Cancer Screening to Drug Selection and Personalized ImmunotherapyXiaolan Deng, Yusuke Nakamura
Seminars in Hematology|June 5, 2003
Prediction of response to imatinib by cDNA microarray analysisRyuzo Ohno, Yusuke Nakamura
Neuropsychiatric Disease and Treatment|May 30, 2017
Productivity and deadweight losses due to relapses of schizophrenia in JapanYusuke Nakamura, Jörg Mahlich
Pageof 105